Company / Capital Expenditures
Entera Bio Ltd. Capital Expenditures History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$3.0K
FY2025
5-year range
$3.0K / $53.0K
FY2021-FY2025
Trend
-82.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $47,000 to $3,000 over the past 2 years.
Based on SEC 10-K filings.
$3,000 in FY2025 with a 3-year CAGR of -43.9%.
Declined from $47,000 to $3,000 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -43.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -43.9%, indicating a declining trend.
- In FY2025, capital expenditures decreased 82.4% year-over-year.
- Peak capital expenditures was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.0K | -82.4% |
| FY2024 | $17.0K | -63.8% |
| FY2023 | $47.0K | +176.5% |
| FY2022 | $17.0K | -67.9% |
| FY2021 | $53.0K | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026